Published in Trends Neurosci on September 01, 2002
Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol (2005) 1.81
Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis (2008) 1.56
Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol (2005) 1.42
PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J (2009) 1.29
Vessel microport technique for applications in cerebrovascular research. J Neurosci Res (2009) 1.28
PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. J Clin Invest (2004) 1.15
Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis. NMR Biomed (2008) 0.94
Metabolic markers of neuronal injury correlate with SIV CNS disease severity and inoculum in the macaque model of neuroAIDS. Magn Reson Med (2008) 0.91
CD8+ lymphocyte depletion without SIV infection does not produce metabolic changes or pathological abnormalities in the rhesus macaque brain. J Med Primatol (2011) 0.87
Blood-brain barrier and retroviral infections. Virulence (2012) 0.85
HIV Dementia. Curr Treat Options Neurol (2004) 0.79
Neurological complications of HIV infection. Lancet Neurol (2005) 3.25
Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol (2010) 2.96
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem (2002) 2.45
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med (2002) 1.63
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem (2002) 1.19
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol (2008) 1.14
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child. J Child Neurol (2012) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
The bone marrow, B cells, and JC virus. J Neurovirol (2008) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. Vaccine (2006) 0.92
Steroids for PML-IRIS: a double-edged sword? Neurology (2009) 0.89
Neuroprotective therapy for HIV dementia. Curr HIV Res (2003) 0.89
Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneap Minn) (2015) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr Opin Neurol (2011) 0.86
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. Am J Otolaryngol (2010) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. Curr Treat Options Neurol (2012) 0.85
Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.85
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy (2006) 0.85
Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J (2002) 0.84
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS (2003) 0.83
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol (2015) 0.83
Spinal epidural abscess. Curr Infect Dis Rep (2014) 0.81
Substantia nigra depigmentation and exposure to encephalitis lethargica. Ann Neurol (2012) 0.81
Alien hand syndrome. Neurology (2006) 0.81
Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs (2015) 0.81
Introduction to HIV infection and neuro-AIDS. Handb Clin Neurol (2007) 0.79
The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep (2011) 0.79
Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology (2003) 0.79
The manifold faces of PML and the challenge of diagnosis. Neurology (2011) 0.79
Disease-modifying drugs for multiple sclerosis and JC virus expression. J Neurovirol (2012) 0.79
Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells. J Neurovirol (2003) 0.78
Autoimmune markers in HIV-associated dementia. J Neuroimmunol (2003) 0.78
Reply to "'Thinking without thinking' about natalizumab and PML". J Neurol Sci (2007) 0.78
An international screening tool for HIV dementia. AIDS (2005) 0.78
Too much of a good thing? IRIS with natalizumab-associated PML. Neurology (2011) 0.77
Primary lateral sclerosis with HIV-1 infection. Neurology (2008) 0.77
HIV and the central nervous system. Compr Ther (2002) 0.77
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. AIDS (2010) 0.76
Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol (2004) 0.76
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol (2014) 0.75
Memory and the mammillothalamic tract. AJNR Am J Neuroradiol (2004) 0.75
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? Neurology (2007) 0.75
Parinaud syndrome heralding MS. Neurology (2003) 0.75
Volitional opsoclonus. Neurology (2005) 0.75
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol (2014) 0.75
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. J Neurovirol (2002) 0.75
Neuro-AIDS in the developing world. Neurology (2012) 0.75
A giant MS plaque mimicking PML during natalizumab treatment. J Neurol Sci (2010) 0.75
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT. Clin Neurol Neurosurg (2008) 0.75
Homonymous hemianopsia complicating treatment of postoperative epistaxis. Neurology (2006) 0.75
Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep (2013) 0.75
The interface of infectious disease and neuro-ophthalmology. J Neuroophthalmol (2012) 0.75
Infectious myelopathies. Continuum (Minneap Minn) (2011) 0.75
Other opportunistic infections of the central nervous system in AIDS. Handb Clin Neurol (2007) 0.75
Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report. J Neurovirol (2012) 0.75
Acute central cord syndrome with bodybuilder sign. Clin Neurol Neurosurg (2007) 0.75
Progressive multifocal leukoencephalopathy. Handb Clin Neurol (2007) 0.75